Canadian Online Pharmacy

CDER New August 21, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

August 20, 2013


New and Generic Drug Approvals

August 19, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Amitiza lubiprostone Capsule; Oral Sucampo Pharms Manufacturing Change or Addition
Colyte polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous For Solution; Oral Meda Pharms Labeling Revision
Colyte With Flavor Packs polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous For Solution; Oral Meda Pharms Labeling Revision
Colyte-Flavored polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous For Solution; Oral Meda Pharms Labeling Revision
Erythrocin erythromycin lactobionate Injectable; Injection Hospira Approval
Januvia sitagliptin phosphate Tablet; Oral Merck Sharp Dohme Labeling Revision
Juvisync simvastatin; sitagliptin phosphate Tablet; Oral Merck Sharp Dohme Labeling Revision
Urso 250 ursodiol Tablet; Oral Aptalis Pharma Us Approval
Urso Forte ursodiol Tablet; Oral Aptalis Pharma Us Approval

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery